These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15924589)

  • 21. The impaired hyperglycemic peak as an additional indicator of Type 2 diabetes development is misdetected.
    Trujillo-Arriaga HM; Román-Ramos R
    Med Hypotheses; 2004; 62(2):268-74. PubMed ID: 14962638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of the oral glucose tolerance test in the evaluation of chronic idiopathic axonal polyneuropathy.
    Hoffman-Snyder C; Smith BE; Ross MA; Hernandez J; Bosch EP
    Arch Neurol; 2006 Aug; 63(8):1075-9. PubMed ID: 16769858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Usefulness of oral glucose tolerance test (OGTT) in output patients with advanced chronic renal failure (CRF)].
    Rufino M; Barbero P; Hernández D; Torres A; Lorenzo V
    Nefrologia; 2007; 27(1):30-7. PubMed ID: 17402877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and characteristics of impaired glucose metabolism in patients referred to comprehensive cardiac rehabilitation: the DANSUK study.
    Boas Soja AM; Zwisler AD; Melchior T; Hommel E; Torp-Pedersen C; Madsen M
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):784-90. PubMed ID: 17001219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Impaired glucose tolerance in patients with acute myocardial infarction].
    Andersen GØ; Eritsland J; Aasheim A; Neuburger J; Knudsen EC; Mangschau A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2264-7. PubMed ID: 16967066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population.
    Guerrero-Romero F; Violante R; Rodríguez-Morán M
    Paediatr Perinat Epidemiol; 2009 Jul; 23(4):363-9. PubMed ID: 19523083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study.
    Valdés S; Botas P; Delgado E; Alvarez F; Cadórniga FD
    Metabolism; 2008 Mar; 57(3):399-403. PubMed ID: 18249214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp.
    Piché ME; Lemieux S; Corneau L; Nadeau A; Bergeron J; Weisnagel SJ
    Metabolism; 2007 Sep; 56(9):1159-66. PubMed ID: 17697856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should oral glucose tolerance testing be mandatory following acute myocardial infarction?
    Jessani S; Gangopadhyay K; Patel JV; Lip GY; Millane T
    Int J Clin Pract; 2007 Apr; 61(4):680-3. PubMed ID: 17394440
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term metabolic changes achieved by weight loss in hypertensive patients.
    Cordero A; Bertomeu-Martínez V; Mazón P; Martín-Raymondi D; Palma JL; Anguita M; Lekuona I; Galve E; González-Juanatey JR
    Int J Cardiol; 2011 Dec; 153(3):286-90. PubMed ID: 20851483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
    Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
    Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of glycemic excursion in different subtypes of impaired glucose intolerance].
    Kang Y; Lu JM; Sun JF; Li CL; Wang XL; Zhang XQ; Lü ZH; Dou JT; Mu YM
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):669-72. PubMed ID: 19595059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening for the detection of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in welfare homes residents from south-eastern region of Poland.
    Grzywa M; Mazur A; Skrzypiec J
    Int J Clin Pract; 2011 Jul; 65(7):818-9. PubMed ID: 21676124
    [No Abstract]   [Full Text] [Related]  

  • 35. Fine-tuning of prediction of isolated impaired glucose tolerance: a quantitative clinical prediction model.
    Rambod M; Hosseinpanah F; Ardakani EM; Padyab M; Azizi F
    Diabetes Res Clin Pract; 2009 Jan; 83(1):61-8. PubMed ID: 19012984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of the glucose metabolism disturbances in screening of adult inhabitants of Krakow].
    Szurkowska M; Szafraniec K; Gilis-Januszewska A; Pach D; Krzentowska A; Szybiński Z; Huszno B
    Przegl Lek; 2006; 63(9):728-32. PubMed ID: 17479858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How to diagnose diabetes.
    Hill J
    Nurs Times; 2005 Apr 19-25; 101(16):28-30. PubMed ID: 15871371
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postprandial lipaemia in patients with impaired fasting glucose, impaired glucose tolerance and diabetes mellitus.
    Madhu SV; Kant S; Srivastava S; Kant R; Sharma SB; Bhadoria DP
    Diabetes Res Clin Pract; 2008 Jun; 80(3):380-5. PubMed ID: 18321605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for overt diabetes by oral glucose tolerance test: stratification by fasting blood glucose and patients' age improve practicability of guidelines in cardiological routine.
    Kempf K; Füth R; Dinh W; Bansemir L; Köhler T; Bufe A; Scheffold T; Standl E; Martin S; Lankisch M
    Int J Cardiol; 2011 Jul; 150(2):201-5. PubMed ID: 20542339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.